Follicular lymphoma grade II, intra-abdominal lymph nodes
ICD-10 C82.13 is a billable code used to indicate a diagnosis of follicular lymphoma grade ii, intra-abdominal lymph nodes.
Follicular lymphoma grade II is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. This subtype is typically indolent but can transform into a more aggressive form. The involvement of intra-abdominal lymph nodes indicates that the lymphoma has spread beyond its original site, which can complicate treatment and prognosis. Patients may present with B-symptoms such as fever, night sweats, and weight loss, which are indicative of systemic disease. Staging is crucial in determining the extent of the disease, with the Ann Arbor staging system commonly used. Treatment protocols often include watchful waiting for asymptomatic patients, while symptomatic cases may require chemotherapy, immunotherapy, or targeted therapies. The prognosis for grade II follicular lymphoma can vary based on factors such as age, overall health, and response to treatment.
Detailed clinical notes on symptoms, staging, and treatment plans.
Patients presenting with lymphadenopathy, B-symptoms, or requiring chemotherapy.
Ensure all treatment modalities and responses are documented to support coding.
Histopathological reports confirming diagnosis and grading.
Biopsy specimens from lymph nodes or bone marrow.
Accurate reporting of histological findings is crucial for coding.
Used to monitor blood counts during treatment.
Document the reason for the CBC and any abnormalities noted.
Hematology specialists should ensure all lab results are linked to the diagnosis.
Common treatments include watchful waiting for asymptomatic patients, chemotherapy regimens such as R-CHOP, and targeted therapies like rituximab. The choice of treatment depends on the patient's symptoms, stage, and overall health.
